← Open Payments lookup

GABRIELLE BROOKS: Open Payments

NPI 1982201745 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$496 in 28 payments from 8 companies in 2025. Trend: 2023 $262 · 2024 $71 · 2025 $496

Food & beverage: $496
CompanyPaymentsAmount
PFIZER INC.12$212
Amgen Inc.5$83
E.R. Squibb & Sons, L.L.C.3$55
Novartis Pharmaceuticals Corporation2$46
Novo Nordisk Inc2$37
AstraZeneca Pharmaceuticals LP2$33
Bayer Healthcare Pharmaceuticals Inc.1$18
Alnylam Pharmaceuticals Inc.1$14

Products named: VYNDAQEL, REPATHA, ELIQUIS, LEQVIO, Wegovy, CAMZYOS, FARXIGA, Kerendia.

Industry payments across AL — which companies pay providers there.